1 Dec 2025
Targeting TXNIP With Saroglitazar Mitigates Acute Hepatic Injury in Rats Challenged With Thioacetamide: A Multistep Computational and Experimental ApproachPublisher siteArchiv der Pharmazie, Redox biology and oxidative stress
Active, last published 2026
In liver disease diagnosis and treatment
George S.G.
Shehatou
Scholar“Research focused on Liver Disease Diagnosis and Treatment and adjacent fields.”
Claim Your Profile16
H-index
760
Citations
George has not officially claimed their profile. If you are George, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
eorge S.G. Shehatou is a researcher working on Liver Disease Diagnosis and Treatment. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
George's work has been cited 760 times across 3 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Liver Disease Diagnosis and Treatment×7Natural Antidiabetic Agents Studies×4Diet, Metabolism, and Disease×4Renal Diseases and Glomerulopathies×3Genomics, phytochemicals, and oxidative stress×3
04 · Where I am
Affiliations
Affiliation on published researchMansoura University, EgyptDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
9 works26 Apr 20253cites
Edaravone protects against cuprizone-induced demyelination in rats by modulating TNF-α/NF-ĸB/NLRP3 signaling and the kynurenine pathwayPublisher siteEuropean Journal of Pharmacology, Tryptophan and brain disorders
30 Dec 2024Open access5cites
L-carnitine attenuates autophagic flux, apoptosis, and necroptosis in rats with dexamethasone-induced non-alcoholic steatohepatitisPublisher siteBMC Pharmacology and Toxicology, Metabolism and Genetic Disorders
7 Nov 20245cites
Diltiazem mitigates acute liver injury by targeting NFκB-TXNIP/NLRP3 axis in Rats: New insights beyond calcium channel blockadePublisher siteInternational Immunopharmacology, Drug-Induced Hepatotoxicity and Protection
4 Oct 20245cites
Metformin's cardioprotective role in isoprenaline-induced myocardial infarction: Unveiling insights into the AMPK, NF-κB, JAK2/STAT3 pathways, and cholinergic regulationPublisher siteLife Sciences, Metabolism, Diabetes, and Cancer
1 Apr 2024Open access1cites
Establishment of dexamethasone model as a model for metabolic-associated hepatic injury in male Wistar ratsPublisher siteDelta University Scientific Journal, Liver Disease Diagnosis and Treatment
30 Nov 20239cites
Saroglitazar mitigated NASH-associated hepatic injury in dexamethasone-treated rats via modulating autophagy, apoptosis, and necroptosisPublisher siteToxicology and Applied Pharmacology, Liver Disease Diagnosis and Treatment
6 Apr 20237cites
RhoA/ROCK inhibition attenuates endothelin-1–induced glomerulopathy in the ratsPublisher siteLife Sciences, Renal Diseases and Glomerulopathies
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you George?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you